Monte Rosa Therapeutics Inc (GLUE)

8.48 -0.15 (-1.74%) USD  |  NASDAQ  |  Nov 14, 16:00
8.48 0.00 (0.00%) After-Hours: 20:00
More

Monte Rosa Therapeutics EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to EBITDA Data

View and export this data back to . Upgrade now.
Date Value

EV to EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

Novartis AG Upgrade
MEI Pharma Inc Upgrade
Evoke Pharma Inc --
Revance Therapeutics Inc --
Vera Therapeutics Inc --

EV to EBITDA Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade